Pharma Focus Asia
KP - Sustainable Packaging Solutions

OBiO Technology Plans to Open New Production Facility in Shanghai, China


OBiO Technology unveiled to construct new state-of-the-art GMP production facility, Intelli-M. for developing advanced therapies in Shanghai, China.


The Intelli-M facility covers an area of 828,000 square feet and is equipped with 29 production lines. It consists of a variety of single-use bioreactors ranging in size from 50 to 2000 litres and features closed downstream processing, allowing for flexibility.

The facility is well-equipped with advanced technologies to support the pharmaceutical and biotechnology sectors.

The site plays a pivotal role in enhancing production and service capabilities in both China and the United States. It covers activities from the proof of concept and investigational new drug (IND) declaration stages to new drug application and commercial manufacturing.

The new production facility will offer comprehensive services worldwide, catering to the increasing demand for contract development and manufacturing organisation (CDMO) solutions in the field of gene therapy accelerating the pace of innovation in the pharmaceutical industry.


Name   OBiO Technology
Type     New Construction

Latest Issue
Get instant
access to our latest e-book
Standard BioTools™MFA + MMA 2024Gibco Adherent Kidney Media PanelTFS - ODW - The Technology Debate: Single-Use vs. Stainless SteelAsia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 20244th Middle East Pharmacoeconomics and Drug Policy Summit 2024Digital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference
Searching for an end-to-end patient tech solution?